Sökning: onr:"swepub:oai:DiVA.org:uu-346657" > Long-Term Outcomes ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07723naa a2200805 4500 | |
001 | oai:DiVA.org:uu-346657 | |
003 | SwePub | |
008 | 180322s2018 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:137569115 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3466572 URI |
024 | 7 | a https://doi.org/10.1002/cncr.311142 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1375691152 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Myers, Regina M.u Childrens Hosp Philadelphia, Div Hematol & Oncol, Philadelphia, PA 19104 USA.4 aut |
245 | 1 0 | a Long-Term Outcomes Among 2-Year Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Diffuse Large B-Cell Lymphoma |
264 | c 2017-11-10 | |
264 | 1 | b WILEY,c 2018 |
338 | a print2 rdacarrier | |
520 | a BACKGROUND: Autologous hematopoietic cell transplantation (auto-HCT) is a standard therapy for relapsed classic Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL); however, long-term outcomes are not well described.METHODS: This study analyzed survival, nonrelapse mortality, late effects, and subsequent malignant neoplasms (SMNs) in 1617 patients who survived progression-free for >= 2 years after auto-HCT for cHL or DLBCL between 1990 and 2008. The median age at auto-HCT was 40 years; the median follow-up was 10.6 years.RESULTS: The 5-year overall survival rate was 90% (95% confidence interval [CI], 87%-92%) for patients with cHL and 89% (95% CI, 87%-91%) for patients with DLBCL. The risk of late mortality in comparison with the general population was 9.6-fold higher for patients with cHL (standardized mortality ratio [SMR], 9.6) and 3.4-fold higher for patients with DLBCL (SMR, 3.4). Relapse accounted for 44% of late deaths. At least 1 late effect was reported for 9% of the patients. A total of 105 SMNs were confirmed: 44 in the cHL group and 61 in the DLBCL group. According to a multivariate analysis, older age, male sex, a Karnofsky score < 90, total body irradiation (TBI) exposure, and a higher number of lines of chemotherapy before auto-HCT were risk factors for overall mortality in cHL. Risk factors in DLBCL were older age and TBI exposure. A subanalysis of 798 adolescent and young adult patients mirrored the outcomes of the overall study population.CONCLUSIONS: Despite generally favorable outcomes, 2-year survivors of auto-HCT for cHL or DLBCL have an excess late-mortality risk in comparison with the general population and experience an assortment of late complications. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a autologous hematopoietic cell transplant | |
653 | a diffuse large B-cell lymphoma | |
653 | a Hodgkin lymphoma | |
653 | a late effects | |
653 | a nonrelapse mortality | |
653 | a survival | |
700 | 1 | a Hill, Brian T.u Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA.4 aut |
700 | 1 | a Shaw, Bronwen E.u Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.4 aut |
700 | 1 | a Kim, Soyoungu Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53226 USA.4 aut |
700 | 1 | a Millard, Heather R.u Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.4 aut |
700 | 1 | a Battiwalla, Minoou NHLBI, Hematol Branch, Bethesda, MD 20892 USA.4 aut |
700 | 1 | a Majhail, Navneet S.u Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA.4 aut |
700 | 1 | a Buchbinder, Davidu Childrens Hosp Orange Cty, Div Pediat Hematol, Orange, CA 92668 USA.4 aut |
700 | 1 | a Lazarus, Hillard M.u Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Seidman Canc Ctr, Cleveland, OH 44106 USA.4 aut |
700 | 1 | a Savani, Bipin N.u Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA.4 aut |
700 | 1 | a Flowers, Mary E. D.u Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.4 aut |
700 | 1 | a D'Souza, Anitau Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.4 aut |
700 | 1 | a Ehrhardt, Matthew J.u St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.4 aut |
700 | 1 | a Langston, Ameliau Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.4 aut |
700 | 1 | a Yared, Jean A.u Univ Maryland, Dept Med, Div Hematol Oncol, Greenebaum Comprehens Canc Ctr,Blood & Marrow Tra, Baltimore, MD 21201 USA.4 aut |
700 | 1 | a Hayashi, Robert J.u Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA.4 aut |
700 | 1 | a Daly, Andrewu Tom Baker Canc Clin, Calgary, AB, Canada.4 aut |
700 | 1 | a Olsson, Richardu Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Div Therapeut Immunol, Dept Lab Med, Stockholm, Sweden4 aut0 (Swepub:uu)riols677 |
700 | 1 | a Inamoto, Yoshihirou Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan.4 aut |
700 | 1 | a Malone, Adriana K.u Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.4 aut |
700 | 1 | a DeFilipp, Zachariahu Massachusetts Gen Hosp, Blood & Marrow Transplant Program, Boston, MA 02114 USA.4 aut |
700 | 1 | a Margossian, Steven P.u Boston Childrens Hosp, Dept Pediat Oncol, Boston, MA USA.;Dana Farber Canc Inst, Boston, MA 02115 USA.4 aut |
700 | 1 | a Warwick, Anne B.u Uniformed Serv Ind Hlth Sci, Dept Pediat, Bethesda, MD USA.4 aut |
700 | 1 | a Jaglowski, Samanthau Ohio State Univ, Med Ctr, Div Hematol, Columbus, OH 43210 USA.4 aut |
700 | 1 | a Beitinjaneh, Ameru Univ Miami, Miami, FL USA.4 aut |
700 | 1 | a Fung, Henryu Fox Chase Canc Ctr, Dept Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.4 aut |
700 | 1 | a Kasow, Kimberly A.u Univ N Carolina, Div Hematol Oncol, Dept Pediat, Chapel Hill, NC USA.4 aut |
700 | 1 | a Marks, David I.u Univ Hosp Bristol NHS Trust, Adult Bone Marrow Transplant, Bristol, Avon, England.4 aut |
700 | 1 | a Reynolds, Janau Baylor Univ, Med Ctr, Dallas, TX USA.4 aut |
700 | 1 | a Stockerl-Goldstein, Keithu Washington Univ, Sch Med, Div Oncol, St Louis, MO USA.4 aut |
700 | 1 | a Wirk, Baldeepu Seattle Canc Care Alliance, Div Bone Marrow Transplant, Seattle, WA USA.4 aut |
700 | 1 | a Wood, William A.u Univ N Carolina, Div Hematol Oncol, Dept Med, Chapel Hill, NC USA.4 aut |
700 | 1 | a Hamadani, Mehdiu Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.4 aut |
700 | 1 | a Satwani, Prakashu Columbia Univ, Med Ctr, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, New York, NY USA.4 aut |
710 | 2 | a Childrens Hosp Philadelphia, Div Hematol & Oncol, Philadelphia, PA 19104 USA.b Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA.4 org |
773 | 0 | t Cancerd : WILEYg 124:4, s. 816-825q 124:4<816-825x 0008-543Xx 1097-0142 |
856 | 4 | u https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.31114 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-346657 |
856 | 4 8 | u https://doi.org/10.1002/cncr.31114 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:137569115 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.